S&S Healthcare Holding Ltd. (TPEX:4198)
Taiwan
· Delayed Price · Currency is TWD 36.80
-2.20 (-5.64%)
Apr 29, 2026, 1:21 PM CST
S&S Healthcare Holding Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 204.21 | 240.25 | 254.52 | 254.44 | 122.35 | Upgrade
|
| Revenue Growth (YoY) | -15.00% | -5.61% | 0.03% | 107.95% | 20.71% | Upgrade
|
| Cost of Revenue | 137.1 | 165.24 | 218.87 | 216.05 | 130.29 | Upgrade
|
| Gross Profit | 67.11 | 75.01 | 35.66 | 38.39 | -7.93 | Upgrade
|
| Selling, General & Admin | 105.45 | 133.38 | 111.9 | 113.92 | 71.61 | Upgrade
|
| Research & Development | 8.89 | 10.04 | 15.11 | 21.38 | 24.33 | Upgrade
|
| Operating Expenses | 113.68 | 142.99 | 128.58 | 148.91 | 95.36 | Upgrade
|
| Operating Income | -46.57 | -67.98 | -92.92 | -110.52 | -103.29 | Upgrade
|
| Interest Expense | -1.03 | -2.17 | -5.24 | -2.37 | -1.74 | Upgrade
|
| Interest & Investment Income | 1.54 | 1.45 | 0.99 | 0.45 | 0.46 | Upgrade
|
| Earnings From Equity Investments | -3.47 | 0.09 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.74 | 1.54 | 1.33 | 4.57 | -0.78 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.69 | 8.66 | 15.06 | 33.43 | 9.99 | Upgrade
|
| EBT Excluding Unusual Items | -49.58 | -58.41 | -80.79 | -74.44 | -95.34 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1.13 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0 | 12.08 | 186.58 | 4.07 | -0.05 | Upgrade
|
| Asset Writedown | - | - | -3.15 | - | - | Upgrade
|
| Other Unusual Items | - | - | 0.21 | - | - | Upgrade
|
| Pretax Income | -48.45 | -46.33 | 102.86 | -70.37 | -95.39 | Upgrade
|
| Income Tax Expense | -0.51 | 2.16 | -0.03 | -1.21 | - | Upgrade
|
| Earnings From Continuing Operations | -47.94 | -48.49 | 102.89 | -69.16 | -95.39 | Upgrade
|
| Minority Interest in Earnings | 0.65 | 7.22 | 0.72 | 2.27 | - | Upgrade
|
| Net Income | -47.3 | -41.28 | 103.61 | -66.89 | -95.39 | Upgrade
|
| Net Income to Common | -47.3 | -41.28 | 103.61 | -66.89 | -95.39 | Upgrade
|
| Shares Outstanding (Basic) | 24 | 24 | 23 | 18 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 24 | 24 | 23 | 18 | 15 | Upgrade
|
| Shares Change (YoY) | - | 4.56% | 30.09% | 21.08% | 18.96% | Upgrade
|
| EPS (Basic) | -1.96 | -1.71 | 4.49 | -3.77 | -6.52 | Upgrade
|
| EPS (Diluted) | -1.96 | -1.71 | 4.49 | -3.77 | -6.52 | Upgrade
|
| Free Cash Flow | -29.12 | -57.74 | -98.7 | -89.07 | -80.04 | Upgrade
|
| Free Cash Flow Per Share | -1.21 | -2.40 | -4.28 | -5.03 | -5.47 | Upgrade
|
| Gross Margin | 32.87% | 31.22% | 14.01% | 15.09% | -6.48% | Upgrade
|
| Operating Margin | -22.80% | -28.30% | -36.51% | -43.44% | -84.42% | Upgrade
|
| Profit Margin | -23.16% | -17.18% | 40.71% | -26.29% | -77.97% | Upgrade
|
| Free Cash Flow Margin | -14.26% | -24.03% | -38.78% | -35.01% | -65.42% | Upgrade
|
| EBITDA | -33.45 | -48.63 | -71.88 | -81.63 | -88.93 | Upgrade
|
| EBITDA Margin | -16.38% | -20.24% | -28.24% | -32.08% | -72.69% | Upgrade
|
| D&A For EBITDA | 13.12 | 19.35 | 21.04 | 28.88 | 14.35 | Upgrade
|
| EBIT | -46.57 | -67.98 | -92.92 | -110.52 | -103.29 | Upgrade
|
| EBIT Margin | -22.80% | -28.30% | -36.51% | -43.44% | -84.42% | Upgrade
|
| Advertising Expenses | - | - | 3.92 | 4.29 | 1.33 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.